This approach offers an enhanced therapeutic effect with minimal systemic toxicity, addressing one of oncology’s ...
Gilead Sciences' Kite unit has showcased three new CAR-T therapies at ASH, headed by multiple myeloma candidate ...
And Simon Kohl, founder and CEO of Latent Labs, knows this intimately. In a new episode of the pharmaphorum podcast, Kohl ...
The company's BCMAxCD3 bispecific antibody Lynozyfic (linvoseltamab) got its first FDA approval as a fifth-line or later ...
In line with its deregulatory stance under new Commissioner Marty Makary, the US regulator has launched TEMPO – ...
Social determinants of health (SDOH) encompass a wide range of non-medical factors that influence health and well-being.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results